Intel Receives FDA Clearance for New Remote Patient Monitoring Device

Published by: IDC

Published: Aug. 15, 2008 - 5 Pages

Table of Contents

Abstract

This Health Industry Insights NewsFlash examines Intel Corp.'s announcement made on July 10, that it had received approval of its application for a 510(k) market clearance from the U.S. Food and Drug Administration (FDA) for its first personal health system, the Intel Health Guide (IHG).

Intel has completed pilot studies in the United States and United Kingdom. In late 3Q08, Intel plans to conduct additional pilot studies with healthcare organizations to understand how the IHG integrates with different care management models in the home and expects it to be commercially available in the United States and United Kingdom in late 4Q08 or early 1Q09.

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 250,000 market research reports, company profiles and country profiles from over 650 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.